Reliability and validity of the Thai version of the PHQ-9

Lotrakul, Manote; Sumrithe, Sutida; Saipanish, Ratana
January 2008
BMC Psychiatry;2008, Vol. 8, Special section p1
Academic Journal
Background: Most depression screening tools in Thailand are lengthy. The long process makes them impractical for routine use in primary care. This study aims to examine the reliability and validity of a Thai version Patient Health Questionnaire (PHQ-9) as a screening tool for major depression in primary care patients. Methods: The English language PHQ-9 was translated into Thai. The process involved backtranslation, cross-cultural adaptation, field testing of the pre-final version, as well as final adjustments. The PHQ-9 was then administered among 1,000 patients in family practice clinic. Of these 1,000 patients, 300 were further assessed by the Thai version of the Mini International Neuropsychiatric Interview (MINI) and the Thai version of the Hamilton Rating Scale for Depression (HAM-D). These tools served as gold-standards for diagnosing depression and for assessing symptom severity, respectively. In the assessment, reliability and validity analyses, and receiver operating characteristic curve analysis were performed. Results: Complete data were obtained from 924 participants and 279 interviewed respondents. The mean age of the participants was 45.0 years (SD = 14.3) and 73.7% of them were females. The mean PHQ-9 score was 4.93 (SD = 3.75). The Thai version of the PHQ-9 had satisfactory internal consistency (Cronbach's alpha = 0.79) and showed moderate convergent validity with the HAM-D (r = 0.56; P < 0.001). The categorical algorithm of the PHQ-9 had low sensitivity (0.53) but very high specificity (0.98) and positive likelihood ratio (27.37). Used as a continuous measure, the optimal cut-off score of PHQ-9 ≥ 9 revealed a sensitivity of 0.84, specificity of 0.77, positive predictive value (PPV) of 0.21, negative predictive value (NPV) of 0.99, and positive likelihood ratio of 3.71. The area under the curve (AUC) in this study was 0.89 (SD = 0.05, 95% CI 0.85 to 0.92). Conclusion: The Thai version of the PHQ-9 has acceptable psychometric properties for screening for major depression in general practice with a recommended cut-off score of nine or greater.


Related Articles

  • Efficacy and Tolerability of Reboxetine in Depressive Patients Treated in Routine Clinical Practice. Messer, Thomas; Schmauss, Max; Lambert-Baumann, Judith // CNS Drugs;2005, Vol. 19 Issue 1, p43 

    Objectives: Reboxetine, a potent and selective noradrenaline reuptake inhibitor, has been approved for treatment of major depression. The aim of this study was to investigate the efficacy and tolerability of reboxetine in depressive outpatients undergoing treatment in routine clinical practice....

  • Depression: Serious, prevalent, detectable. Millard, William B. // Patient Care;2/15/1994, Vol. 28 Issue 3, p30 

    Offers information for primary care physicians on diagnosing mental depression. Lifetime rate of nonmood psychiatric disorders; Biomedical model for depression; Agency for Health Care Policy and Research's (AHCPR) sponsorship of primary care guidelines. INSETS: The depression guideline...

  • PHQ-9. Syed, Taz // British Journal of General Practice;Mar2013, Vol. 63 Issue 608, p14 

    A letter to the editor is presented which expresses concerns on the alteration of depression assessment in primary care in Great Britain through the introduction of the Patient Health Questionnaire-9 (PHQ-9).

  • Depression often goes undetected in primary care practice. Conill, Alicia M. // Modern Medicine;Jun97, Vol. 65 Issue 6, p20 

    Emphasizes the need for primary care physicians to make a greater effort to look for depression in patients who make routine appointments in general check-up. Reasons for the undiagnosis of depression in primary care practice; Tips in convincing patients diagnosed with depression.

  • CES-D is not a good test for detecting depression in primary care practice.  // Modern Medicine;Feb98, Vol. 66 Issue 2, p26 

    Discusses the abstract `Can Case-Finding Instruments Be Used to Improve Physician Detection of Depression in Primary Care?' by M.S. Klinkman, J.C. Coyne, S. Gallo et al., which appeared in the November/December 1997 issue of `Archives of Family Medicine.'

  • An Evaluation of a Computer-Based Psychiatric Assessment: Evidence for Expanded Use. Cawthorpe, David // CyberPsychology & Behavior;Aug2001, Vol. 4 Issue 4, p503 

    The purpose of this study was to examine the psychiatric diagnoses of depression made using the structured interview, the Computer-Based Diagnostic Inventory Schedule for Children - Revised (CDISC-R) and diagnoses of depression made by pediatric psychiatrists. One hundred and twenty-two...

  • Depression in lung cancer patients: is the HADS an effective screening tool? Lorys Castelli; Luca Binaschi; Paola Caldera; Riccardo Torta // Supportive Care in Cancer;Aug2009, Vol. 17 Issue 8, p1129 

    Introduction  The present study aimed at comparing the efficacy in recognizing depression, in 53...

  • The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Mondolo, Federica; Jahanshahi, Marjan; Granà, Alessia; Biasutti, Emanuele; Cacciatori, Emanuela; di Benedetto, Paolo // Behavioural Neurology;2006, Vol. 17 Issue 2, p109 

    We assessed the concurrent validity of the Hospital Anxiety and Depression Scale (HADS) and the Geriatric Depression Scale (GDS) against the Hamilton Rating Scale for Depression (Ham-D) in patients with Parkinson's disease (PD). Forty-six non-demented PD patients were assessed by a neurologist...

  • Joint Modeling of Efficacy, Dropout, and Tolerability in Flexible-Dose Trials: A Case Study in Depression. Russu, A; Marostica, E; De Nicolao, G; Hooker, A C; Poggesi, I; Gomeni, R; Zamuner, S // Clinical Pharmacology & Therapeutics;May2012, Vol. 91 Issue 5, p863 

    Many difficulties may arise during the modeling of the time course of Hamilton Rating Scale for Depression (HAMD) scores in clinical trials for the evaluation of antidepressant drugs: (i) flexible designs, used to increase the chance of selecting more efficacious doses, (ii) dropout events, and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics